ClassID:

91384

C07C43/196 - CPC Classification

Classification description:

Ethers; Compounds having groups, groups or groups; Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups

Recent Application in this class:
#1
20240336640
2024-10-10

CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS

#2
20230100818
2023-03-30

NOVEL COMPOUND, CROSSLINKING AGENT AND CROSSLINKED FLUOROELASTOMER

#3
20230092979
2023-03-23

Tripartite androgen receptor eliminators, methods and uses thereof

#4
20210338849
2021-11-04

COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#5
20210179521
2021-06-17

Organoleptic compounds

#6
20210061751
2021-03-04

ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS

#7
20200331828
2020-10-22

NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME

#8
20200207770
2020-07-02

Synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′methylene-carbocyclic guanosine (FMCG)

#9
20200207753
2020-07-02

Tripartite androgen receptor eliminators, methods and uses thereof

#10
20200095230
2020-03-26

SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS

#11
20190381199
2019-12-19

Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

#12
20190282514
2019-09-19

Medicinal use of serrulatane diterpenes

#13
20190161479
2019-05-30

Compounds

#14
20190100523
2019-04-04

Synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′-methylene-carbocyclic guanosine (FMCG)

#15
20190085373
2019-03-21

Chemical tools for imaging phospholipase D activity

#16
20190084966
2019-03-21

Synthetic route to anti-viral agents

#17
20190002380
2019-01-03

Compounds which activate estrogen receptors and compositions and methods of using the same

#18
20180057482
2018-03-01

Synthetic route to anti-viral agents

#19
20170240495
2017-08-24

Polyether diol and method for producing the same

#20
20170233365
2017-08-17

Cyclooctenes for bioorthogonol reactions

#21
20160332947
2016-11-17

Cyclohexanols and their use in perfume compositions

#22
20160332946
2016-11-17

Cyclohexanols and their use in perfume compositions

#23
20160237056
2016-08-18

Synthesis routes for prostaglandins and prostaglandin intermediates using metathesis

#24
20160090467
2016-03-31

Resin composition, film, polarizing plate protective film, polarizing plate, liquid crystal display device, and bis type alicyclic cardo phenol compound

#25
20160017258
2016-01-21

Cyclohexanols and their use in perfume compositions

#26
20160016880
2016-01-21

Bicyclo [2.2.1] acid GPR120 modulators

#27
20160016873
2016-01-21

Cyclohexanols and their use in perfume compositions

#28
20150119435
2015-04-30

COMPOUNDS USEFUL FOR PROMOTING PROTEIN DEGRADATION AND METHODS USING SAME

#29
20150118172
2015-04-30

Use of dicyclohexylmethanol derivatives having antimicrobial properties

#30
20150118165
2015-04-30

USE OF CYCLOHEXANOL ETHERS HAVING ANTIMICROBIAL PROPERTIES

#31
20150105591
2015-04-16

Method for scale extraction Quebrachitol from natural rubber industry waste water

#32
20150098903
2015-04-09

Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders

#33
20150087856
2015-03-26

MELANIN PRODUCTION INHIBITOR

#34
20150072029
2015-03-12

Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases

#35
20150065753
2015-03-05

Process for producing phenol and cyclohexanone

#36
20140155480
2014-06-05

Scyllo-Inositol Derivatives and Their Use in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation of Amyloid Formation, Deposition, Accumulation for Persistence

#37
20130184353
2013-07-18

Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases

#38
20130004896
2013-01-03

Compound for resist and radiation-sensitive composition specification

#39
20110201809
2011-08-18

Process for preparing entecavir and its intermediates

#40
20110165516
2011-07-07

Compound for resist and radiation-sensitive composition

#41
20110124912
2011-05-26

MONOETHERIFIED DIOLS OF DIAMONDOIDS

#42
20110065929
2011-03-17

Homogeneous asymmetric hydrogenation catalyst

#43
20110060138
2011-03-10

Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

#44
20110004005
2011-01-06

RHODIUM-PHOSPHORUS COMPLEXES AND THEIR USE IN RING OPENING REACTIONS

#45
20100168440
2010-07-01

Homogeneous asymmetric hydrogenation process

#46
20100137615
2010-06-03

Homogeneous asymmetric hydrogenation process

#47
20100105631
2010-04-29

Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or Persistence

#48
20090299102
2009-12-03

Apparatus and method for carrying out multiple reactions

#49
20090203927
2009-08-13

Homogeneous asymmetric hydrogenation catalyst

#50
20090170957
2009-07-02

SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE

#51
20090149665
2009-06-11

Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same

#52
20080300271
2008-12-04

Novel compounds and a novel process for their preparation

#53
20080113294
2008-05-15

Compound for resist and radiation-sensitive composition

#54
20070225378
2007-09-27

Menthol derivative and cooling agent composition comprising the same

#55
20070207413
2007-09-06

Photoresists comprising polymers derived from fluoroalcohol-substituted polycyclic monomers

#56
20070111970
2007-05-17

Inositol compounds and uses of same in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence

#57
20060287558
2006-12-21

Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions

#58
20060275701
2006-12-07

Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions

#59
20060135624
2006-06-22

Natural compound useful for treating diabetes, its preparation and use

#60
20060128575
2006-06-15

Traction fluid composition

#61
20060074263
2006-04-06

Fluorine-containing vinyl ethers, their polymers, and resist compositions using such polymers

#62
20050272708
2005-12-08

Akt inhibitors, pharmaceutical compositions, and uses thereof

#63
20050203317
2005-09-15

Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers

#64
20050090688
2005-04-28

Metallized mesoporous silicate and method of oxidation with the same

#65
20050037289
2005-02-17

Bridged carbocyclic compounds and methods of making and using same

#66
20050014721
2005-01-20

Compounds and a novel process for their preparation

#67
14802372
2017-11-07

Synthetic route to anti-viral agents